Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vistagen Therapeutics (VTGN) Amortizatization of Intangibles (2020 - 2025)

Vistagen Therapeutics' Amortizatization of Intangibles history spans 7 years, with the latest figure at $135000.0 for Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles rose 10.66% year-over-year to $135000.0; the TTM value through Dec 2025 reached $522000.0, up 10.36%, while the annual FY2025 figure was $485000.0, 9.98% up from the prior year.
  • Amortizatization of Intangibles for Q4 2025 was $135000.0 at Vistagen Therapeutics, up from $132000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $190500.0 in Q3 2021 and bottomed at $92500.0 in Q1 2021.
  • The 4-year median for Amortizatization of Intangibles is $120000.0 (2024), against an average of $122407.7.
  • The largest annual shift saw Amortizatization of Intangibles increased 7.77% in 2021 before it increased 10.66% in 2025.
  • A 4-year view of Amortizatization of Intangibles shows it stood at $190500.0 in 2021, then tumbled by 41.21% to $112000.0 in 2023, then increased by 8.93% to $122000.0 in 2024, then increased by 10.66% to $135000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTGN's Amortizatization of Intangibles are $135000.0 (Q4 2025), $132000.0 (Q3 2025), and $129000.0 (Q2 2025).